Bioavailability of Potassium From Potatoes and Potassium Gluconate
Potato
1 other identifier
interventional
45
1 country
1
Brief Summary
This study is designed to compare the effect of sources of potassium on uptake and the effect of potassium on blood pressure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
June 17, 2013
CompletedFirst Posted
Study publicly available on registry
June 19, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedMay 9, 2018
May 1, 2018
1.4 years
June 17, 2013
May 3, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bioavailability of Potassium
After 4 days of acclimation to the supplementation, absorption of potassium will be measured.
5 days
Secondary Outcomes (1)
Blood Pressure Response to Potassium
6 days
Study Arms (9)
Placebo control
PLACEBO COMPARATORSubjects will consume tablets containing no potassium in addition to a basal diet containing 2336 mg potassium
Low dose potassium gluconate
EXPERIMENTALSubjects will consume 720 mg potassium in the form of potassium gluconate tablets daily in addition to a basal diet containing 2336 mg potassium
Medium dose potassium gluconate
EXPERIMENTALSubjects will consume 1440 mg potassium in the form of potassium gluconate tablets daily in addition to a basal diet containing 2336 mg potassium
High dose potassium gluconate
EXPERIMENTALSubjects will consume 2160 mg potassium in the form of potassium gluconate tablets daily in addition to a basal diet containing 2336 mg potassium
Low dose potato
EXPERIMENTALSubjects will consume 720 mg potassium in the form of potato daily in addition to a basal diet containing 2336 mg potassium
Medium dose potato
EXPERIMENTALSubjects will consume 1440 mg potassium in the form of potato daily in addition to a basal diet containing 2336 mg potassium
High dose potato
EXPERIMENTALSubjects will consume 2160 mg potassium in the form of potato daily in addition to a basal diet containing 2336 mg potassium
High dose French fries
EXPERIMENTALSubjects will consume 2160 mg potassium in the form of french fries daily in addition to a basal diet containing 2336 mg potassium
Basal diet control
EXPERIMENTALSubjects will consume a basal diet containing 2336 mg potassium daily
Interventions
Eligibility Criteria
You may qualify if:
- Able to adhere to the visit schedule, protocol requirements and available to complete the study
- Normotensive men and women
- Aged 20-60 years
- BMI of 15-35
You may not qualify if:
- Medication to treat hypertension or hypotension
- Medication known to affect electrolyte metabolism or contain high levels of potassium or sodium
- smoke cigarettes or use illegal drugs
- Hypertension or hypotension
- Diseases known to affect potassium metabolism
- Pregnant
- Allergic to nuts
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Purdue Universitylead
- Alliance for Potato Research and Educationcollaborator
Study Sites (1)
Purdue University
West Lafayette, Indiana, 47907, United States
Related Publications (1)
Macdonald-Clarke CJ, Martin BR, McCabe LD, McCabe GP, Lachcik PJ, Wastney M, Weaver CM. Bioavailability of potassium from potatoes and potassium gluconate: a randomized dose response trial. Am J Clin Nutr. 2016 Aug;104(2):346-53. doi: 10.3945/ajcn.115.127225. Epub 2016 Jul 13.
PMID: 27413123DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Connie M Weaver, Ph.D.
Purdue University
- STUDY DIRECTOR
Berdine R Martin, Ph.D.
Purdue University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Scientist
Study Record Dates
First Submitted
June 17, 2013
First Posted
June 19, 2013
Study Start
March 1, 2013
Primary Completion
August 1, 2014
Study Completion
December 1, 2014
Last Updated
May 9, 2018
Record last verified: 2018-05